Notch signaling pathway and cancer metastasis

Advances in Experimental Medicine and Biology

Volumn 727, Issue , 2012, Pages 186-198

  Hu, Yi Yang ^a   Zheng, Min Hua ^a   Zhang, Rui ^a   Liang, Ying Min ^a   Han, Hua ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NOTCH RECEPTOR;

ANGIOGENESIS; ANOIKIS; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER STEM CELL; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; LYMPHANGIOGENESIS; MELANOMA; METASTASIS; NONHUMAN; OSTEOSARCOMA; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STOMACH CANCER; TUMOR VASCULARIZATION; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY; REVIEW;

ANIMALS; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84859478908     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0899-4_14     Document Type: Article

References (84)

1. Eccies SA, Welch DR. Metastasis: Recent discoveries and novel treatment strategies. Lancet 2007; 369:1742-1757.
2. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009; 1796:293-308.
3. Kaplan RN, Riba RD, Zacharoulis S et al. VEGFR1 -positive haematopoietic bone manow progenitors initiate the premetastatic niche. Nature 2005; 438:820-827.
4. Greenburg O, Hay ED. Cytoskeleton and thyroglobulin expression change during transformation of thyroid epithelium to mesenchyme-like cells. Development 1988; 102:605-622.
5. Jechlinger M, Grunert S, Tamir IH et al. Expression profiling of epithelial plasticity in tumor progression. Oncogene 2003; 22:7155-7169.
6. Christofori O, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 1999; 24:73-76.
7. Friedl P, Wolf K. Tumour-cell invasion and migration: Diversity and escape mechanisms. Nat Rev Cancer 2003 ;3 :3 62-3 74.
8. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
9. Bell CD, Waizbard E. Variability of cell size in primary and metastatic human breast carcinoma. Invasion Metastasis 1986; 6:11-20.
10. Nabeshima K, Inoue T, Shimao Y et al. Cohort migration of carcinoma cells: Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets. Histol Histopathol 1999; 14:1183-1197.
11. Gunthert U, Hofmann M, Rudy Wet al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65:13-24.
12. Padua D, Zhang XH, Wang Q et al. TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133:66-77.
13. Felding-Habermann B, O 'Toole TE, Smith JW et al. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 2001; 98:1853-1858.
14. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994; 124:6 19-62 6.
15. Geiger TR, Peeper DS. The neurotrophic receptor TrkB in anoikis resistance and metastasis: A perspective. Cancer Res 2005; 65:7033-7036.
16. Frisch SM, Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 1997; 9:701-706.
17. Avizienyte E, Wyke AW, Jones RI et al. Src-induced dc-regulation of E-cadherin in colon cancer cells requires integrin signalling. Nat Cell Biol 2002; 4:632-638.
18. Douma S, Van Laar T, Zevenhoven J et al. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB. Nature 2004; 430:1034-1039.
19. Gimbrone MA Jr, Leapman SB, Cotran RS et al. Tumor dormancy invivo by prevention ofneovascularization. J Exp Med 1972; 136:261-276.
20. Hashizume H, Baluk P, Morikawa et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000; 156:1363-1380.
21. Sullivan R, Graham CH. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev 2007; 26:319-331.
22. Cao Y. Opinion: Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat Rev Cancer 2005; 5:735-743.
23. Stacker SA, Achen MG, Jussila Let al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2:573-583.
24. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 1989; 8:98-101.
25. Fidler IJ. The pathogenesis of cancer metastasis: The 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003; 3:453-458.
26. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia afler transplantation into SCID mice. Nature 1994; 367:645-648.
27. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3:730-737.
28. Al-Hajj M, Wicha MS, Benito-Hernandez A et al. Prospective identification of tumorigenic breast cancer cells. Proc Nati Acad Sci USA 2003; 100:3983-3988.
29. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63:5821-5828.
30. Ho MM, Ng AV, Lam S et al. Side population in human lung cancer cell lines and tumors is enriched ith stem-like cancer cells. Cancer Res 2007; 67:4827-4833.
31. Mani SA, Quo W, Liao MJ et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-715.
32. Hermann PC, Huber SL, Henler T et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313-323.
33. Berezovska OP, Glinskii AB, YangZ et al. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer. Cell Cycle 2006; 5:1886-1901.
34. Wharton KA, Johansen KM, Xu T et al. Nucleotide sequence from the neurogenic locus Notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell 1985; 43:567-581.
35. Bray SJ. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7:678-689.
36. Martinez Arias A, Zecchini V, Brennan K et al. CSL-independent Notch signalling: A checkpoint in cell fate decisions during development? Cun Opin Genet Dcv 2002; 12:524-533.
37. Kopan R, Ilagan MX. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 2009; 137:216-233.
38. Koch U, Radtke F. Notch and cancer: A double-edged sword. Cell Mol Life Sci 2007; 64:2746-2762.
39. Haines N, Irvine KD. Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol 2003; 4:786-797.
40. Ilagan MX, Kopan R. SnapShot: Notch signaling pathway. Cell 2007; 128:1246.
41. Longhi A, Enani C, Dc Paolis M et al. Primary bone osteosarcoma in the pediatric age: State of the art. Cancer Treat Rev 2006; 32:423-43 6.
42. Bulman MP, Kusumi K, Frayling TM et al. Mutations in the human delta homologue, DLL3, cause axial skeletal defects in spondylocostal dysostosis. Nat Genet 2000; 24:438-441.
43. Sciaudone M, Gazzeno E, Priest L et al. Notch 1 impairs osteoblastic cell differentiation. Endocrinology 2003; 144:5631-5639.
44. Schnabel M, Fichtel I, Gotzen L et al. Differential expression of Notch genes in human osteoblastic cells. Tnt J Mol Med 2002; 9:229-232.
45. Zhang P, Yang Y, Zweidler-McKay PAct al. Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008; 14:2962-2969.
46. Callahan R, Egan SE. Notch signaling in mammary development and oncogenesis. J Mammary Gland Biol Neoplasia 2004; 9:145-163.
47. Leong KG, Niessen K, Kulic I etal. Jaggedi-mediatedNotch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 2007; 204:2935-2948.
48. Chen J, Imanaka N, Chen J et al. Hypoxia potentiates Notch signaling in breast cancer leading to decreased E-cadherin expression and increased cell migration and invasion. Br J Cancer 2010; 102:351-360.
49. Martin TA, Goyal A, Watkins O et al. Expression of the transcription factors snail, slug and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005; 12:48 8-496.
50. Martin DB, Gifford DR, Wright MEet al. Quantitative proteomic analysis ofproteins released by neoplastic prostate epithelium. Cancer Res 2004; 64:347-355.
51. Shou J, Ross S, Koeppen H et al. Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 2001; 61:7291-7297.
52. Santagata S, Demichelis F, Riva A.et al. JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 2004; 64:6854-6857.
53. Chin L. The genetics ofmalignantmelanoma: Lessons frommouse andman. Nat Rev Cancer 2003;3 :559-570.
54. Hendrix MJ, Seflor EA, Seflor RE et al. Reprogramming metastatic tumour cells with embryonic microenvironments. Nat Rev Cancer 2007; 7:246-255.
55. Hock K, Rimm DL, Williams KR et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004; 64:5270-5282.
56. Balint K, Xiao M, Pimjix CC et al. Activation of Notchi signaling is required for beta-catenin-mediated human primary melanoma progression. J Clin Invest 2005; 115:3166-3176.
57. Liu ZJ, Xiao M, Balint K et al. Notchi signaling promotes primary melanoma progression by activating mitogen-activatedproteinkinase phosphatidylinositol 3-kinase-Aktpathways andup-regulatingN-cadherin expression. Cancer Res 2006; 66:4183-4190.
58. Wang Z, Banerjee S, Li Y et al. Down-regulation of notch-i inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor and matrix metalloproteinase-9 in pancreatic cancer cells. Cancer Res 2006; 66:2778-2784.
59. Yeh TS, Wu CW, Hsu KW et al. The activated Notchl sigoal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res 2009; 69:5039-5045.
60. Veenendaal LM, Kranenburg O, Smakman N et al. Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol 2008; 30:1-11.
61. WangYC, HuXB, HeF et al. Lipopolysaccharide-induced maturation ofbone marrow-derived dendritic cells is regulatedby notch signaling through the up-regulation of CXCR4. J Biol Chem 2009; 284:15993-6003.
62. Sahlgren C, Gustafsson MV, Jin S et al. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 2008; 105:6392-6397.
63. Yang J, Weinberg RA. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dcv Cell 2005; 14:818-829.
64. Blokzijl A, Dahlqvist C, Reissmann E et al. Cross-tallc between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3. J Cell Biol 2003; 163:723-728.
65. Zavadil J, Cermak L, Soto-Nieves Net al. Integration of TGF-beta Smad and Jagged 1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 2004; 23:1155-1 165.
66. Zheng MH, Shi M, Pci Z et al. The transcription factor RBP-J is essential for retinal cell differentiation and lamination. Mol Brain 2009; 2:38.
67. Phng LK, Gerhardt H. Angiogenesis: A team effort coordinated by notch. Dcv Cell 2009; 16:196-208.
68. Duarte A, Hirashima M, Benedito Ret al. Dosage-sentitive requirement formouse D114 inartery development. Genes Dcv 2004; 18:2474-2478.
69. Suchting S, Freitas C, le Noble F et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007; 104:3225-3230.
70. Patel NS, Li JL, Generali D et al. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 2005; 65:8690-8697.
71. Williams CK, Segana M, Siena Mdc L et al. Regulation of CXCR4 by the Notch ligand delta-like 4 in endothelial cells. Cancer Res 2005; 65:1 889-1 895.
72. Dou GR. Wang YC. Hu XB et al. RBP-J. the transcription factor downstream ofNotch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB J 2008; 22:1606-1617.
73. ScehnetJS, Jiang W, Kumar SRetal. Inhibition of D114-mediated signaling induces proliferation of immature vessels and results in poor tissue perfusion. Blood 2007; 109:4753-4760.
74. Ridgway J, Zhang G, Wu Y et al. Inhibition of D114 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444:1083-1087.
75. Noguera-Troise I, Daly C, Papadopoulos NJ et al. Blockade of D114 inhibits tumour growth by promoting nonproductive angiogenesis. Nature 2006; 444:1032-1037.
76. Thurston G, Noguera-Troise I, Yancopoulos GD et al. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 2007; 7:327-331.
77. Samson RC, Hanis AL. Anti-D114 therapy: Can we block tumour growth by increasing angiogenesis? Trends Mol Med 2007; 13:389-395.
78. Steeg PS. Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 2006; 12:895-904.
79. Gupta GP, Nguyen DX, Chiang AC et al. Mediators of vascular remodelling co-opted for sequential steps in lung netasta,i,. Nature 2007; 446:765-770.
80. Hu XB, Feng F, Wang YC et al. Blockade of Notch signaling in tumor-bearing mice may lead to tumor regression, progression, or metastasis, depending on tumor cell types. Neoplasia 2009; 11:32-38.
81. Rangarajan A, Syal R, Selvarajah S et al. Activated Notchl signaling cooperates with papillomavirus oncogenes in transformation and generates resistance to apoptosis on matrix withdrawal through PKB Akt. Virology 2001;286:23-30.
82. Hanison H, Farnie G, Howell SJ et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res 2010; 70:709-718.
83. Fan X, Khaki L, Zhu TS et al. Notch pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografls. Stem Cells 2009; 28:5-16.
84. Wang YC, He F, Feng F et al. Notch signaling determines the Ml versus M2 polarization of macrophages in anti-tumor immune responses. Cancer Res 2010;70(12):4840-4849.